Drug utilization and teratogenicity risk categories during pregnancy

Advances in Therapy

Volumn 24, Issue 1, 2007, Pages 68-80

  Basgül, Alin ^a,b   Akici, Ahmet ^a   Uzuner, Arzu ^a   Kalaça, Sibel ^a   Kavak, Zehra N ^a   Tural, Alper ^a   Oktay, Sule ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Drug utilization; Preconception care; Pregnancy; Teratogenicity

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; FOLIC ACID; HORMONE; IRON; MINERAL; VITAMIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG UTILIZATION; FEMALE; FETUS RISK; FIRST TRIMESTER PREGNANCY; FOOD AND DRUG ADMINISTRATION; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INCOME; INTERVIEW; MATERNAL AGE; MATERNAL CARE; PREGNANCY; PREGNANT WOMAN; QUESTIONNAIRE; RISK; TERATOGENICITY; VITAMIN INTAKE;

EID: 34247868031     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02849994     Document Type: Article

References (24)

1. Lagoy CT, Joshi N, Cragan JD, Rasmussen SA. Medication use during pregnancy and lactation: an urgent call for public health action. J Womens Health (Larchmt). 2005;14:104-109.
2. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;338:1128-1137.
3. De Santis M, Straface G, Carducci B, et al. Risk of drug-induced congenital defects. Eur J Obstet Gynecol Reprod Biol. 2004;117:10-19.
4. Rubin P. Drug treatment during pregnancy. BMJ. 1998;317:1503-1506.
5. Weiner CP, Buhimschi C, Swaan P. Drug-prescribing challenges during pregnancy. Curr Obstet Gynaecol. 2005;15:157-165.
6. Vickers M, Brackley K. Drugs in pregnancy. Curr Obstet Gynaecol. 2002;12:131-137.
7. Suresh L, Radfar L. Pregnancy and lactation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:672-682.
8. Hansen WF, Peacock AE, Yankowitz J. Safe prescribing practices in pregnancy and lactation. J Midwifery Womens Health. 2002;47:409-421.
9. Buitendijk S, Bracken MB. Medication in early pregnancy: prevalence of use and relationship to maternal characteristics. Am J Obstet Gynecol. 1991;165:33-40.
10. Shehata HA, Nelson-Piercy C. Drugs to avoid in pregnancy. Curr Obstet Gynaecol. 2000;10:44-52.
11. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191:398-407.
12. Eskazan E, Aslan S. Antiepileptic therapy and teratogenicity in Turkey. Int J Clin Pharmacol Ther Toxicol. 1992;30:261-264.
13. Yaris F, Ulku C, Kesim M, et al. Psychotropic drugs in pregnancy: a case-control study. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:333-338.
14. ATC/DDD (Anatomic Therapeutic Chemical Classification With Defined Daily Doses) Index 2006. Anatomic Therapeutic Chemical Classification System. Available at: http://www.whocc.no/ atcddd/indexdatabase/. Accessed May 2, 2006.
15. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL. Prescription of drugs during pregnancy in France. Lancet. 2000;356:1735-1736.
16. Olesen C, Steffensen FH, Nielsen GL, de Jong-van den berg L, Olsen J, Sorensen HT. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP Group. Eur J Clin Pharmacol. 1999;55:139-144.
17. Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilisation) studies. Eur J Clin Pharmacol. 1990;38:325-328.
18. Donati S, Baglio G, Spinelli A, Grandolfo ME. Drug use in pregnancy among Italian women. Eur J Clin Pharmacol. 2000;56:323-328.
19. Jiménez E, Bosch F, Lopez A, Costa J, Cos R, Banos JE. Patterns of regular drug use in Spanish childbearing women: changes elicited by pregnancy. Eur J Clin Pharmacol. 1998;54:645-651.
20. De Vigan C, De Walle HEK, Cordier S, et al. Therapeutic drug use during pregnancy: a comparison in four European countries. J Clin Epidemiol. 1999;52:977-982.
21. Czeizel AE. The primary prevention of birth defects: multivitamins or folic acid? Int J Med Sci. 2004;1:50-61.
22. Czeizel AE. Birth defects are preventable. Int J Med Sci. 2005;2:91-92.
23. Eichholzer M, Tönz O, Zimmermann R. Folic acid: a public-health challenge. Lancet. 2006;367:1352-1361.
24. Turkey Demographic and Health Survey TDHS-2003. Available at: http://www.hips. hacettepe.edu.tr/tnsa2003eng/index.htm. Accessed March 7, 2006.